Shahram Hejazi

Shahram has been working with Integral Molecular since 2011, guiding strategic, operational, and sales decisions. With more than 20 years of financial and operational experience, he has founded or directed more than two dozen start-up companies, and has been involved in executive general management of large global companies and early-stage ventures.  As Managing Director and CEO of BioAdvance, Shahram focuses on investments in devices, diagnostics, research tools, and health IT and serves on the Boards of 7 companies. He is also the founder and CEO of Optimeos Life Sciences, an mRNA therapeutic platform biotechnology company, and is faculty at Princeton University where he teaches courses on venture capital and entrepreneurship.

Previously, Shahram served as the President of Kodak’s Molecular Imaging division, the CEO of Zargis Medical, and the Global Head of the Strategic Business Development at Siemens Medical. Shahram earned his Ph.D. in Electrical Engineering from SUNY-Buffalo and an executive business education from Stanford University.